Nationwide Fund Advisors’ Top Q3 Healthcare Stock Holdings: JNJ, ISRG, MRK

Wall St. Watchdog reveals information regarding Nationwide Fund Advisors’ top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 314 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $63.77 million.

  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Nationwide Fund Advisors reported holding 138,975 shares with a market value of $9,244,617. This comprised 1.01% of the total portfolio. On 09/30/2011, Nationwide Fund Advisors reported holding 142,866 shares with a market value of $9,099,135. This comprised 1.34% of the total portfolio. The net change in shares for this position over the two quarters is 3,891. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Intuitive Surgical Inc. (NASDAQ:ISRG): On 06/30/2011, Nationwide Fund Advisors reported holding 13,428 shares with a market value of $4,996,693. This comprised 0.55% of the total portfolio. On 09/30/2011, Nationwide Fund Advisors reported holding 12,735 shares with a market value of $4,639,106. This comprised 0.68% of the total portfolio. The net change in shares for this position over the two quarters is -693. About Company: Intuitive Surgical, Inc. design, manufactures and markets surgical systems. The Company’s surgical system controls Intuitive Surgical endoscopic instruments, including rigid endoscopes, blunt and sharp endoscopic dissectors, scissors, scalpels, forceps/pickups, needle holders, endoscopic retractors, electrocautery, ultrasonic cutters, and accessories during surgical procedures.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Nationwide Fund Advisors reported holding 106,255 shares with a market value of $3,749,739. This comprised 0.41% of the total portfolio. On 09/30/2011, Nationwide Fund Advisors reported holding 104,445 shares with a market value of $3,415,352. This comprised 0.5% of the total portfolio. The net change in shares for this position over the two quarters is -1,810. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, Nationwide Fund Advisors reported holding 75,045 shares with a market value of $3,870,821. This comprised 0.42% of the total portfolio. On 09/30/2011, Nationwide Fund Advisors reported holding 68,953 shares with a market value of $3,180,112. This comprised 0.47% of the total portfolio. The net change in shares for this position over the two quarters is -6,092. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Perrigo Co. (NASDAQ:PRGO): On 06/30/2011, Nationwide Fund Advisors reported holding 20,750 shares with a market value of $1,823,303. This comprised 0.2% of the total portfolio. On 09/30/2011, Nationwide Fund Advisors reported holding 26,461 shares with a market value of $2,569,628. This comprised 0.38% of the total portfolio. The net change in shares for this position over the two quarters is 5,711. About Company: Perrigo Company manufactures store brand over-the-counter pharmaceutical products and also manufactures store brand nutritional products. The Company’s customers include major national and regional retail drug, supermarket, and mass merchandise chains such as Albertson’s, CVS, and Target, and major wholesalers such as Super Valu and McKesson.
  • Biogen Idec Inc. (NASDAQ:BIIB): On 06/30/2011, Nationwide Fund Advisors reported holding 10,716 shares with a market value of $1,145,755. This comprised 0.13% of the total portfolio. On 09/30/2011, Nationwide Fund Advisors reported holding 22,891 shares with a market value of $2,132,297. This comprised 0.31% of the total portfolio. The net change in shares for this position over the two quarters is 12,175. About Company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.
  • Watson Pharmaceuticals Inc. (NYSE:WPI): On 06/30/2011, Nationwide Fund Advisors reported holding 16,298 shares with a market value of $1,120,162. This comprised 0.12% of the total portfolio. On 09/30/2011, Nationwide Fund Advisors reported holding 29,073 shares with a market value of $1,984,232. This comprised 0.29% of the total portfolio. The net change in shares for this position over the two quarters is 12,775. About Company: Watson Pharmaceuticals, Inc. develops, manufactures, and sells generic and brand name pharmaceutical products. The Company’s core focus is specialty products, nephrology, urology, and generic products.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Nationwide Fund Advisors reported holding 119,517 shares with a market value of $2,462,050. This comprised 0.27% of the total portfolio. On 09/30/2011, Nationwide Fund Advisors reported holding 111,399 shares with a market value of $1,969,534. This comprised 0.29% of the total portfolio. The net change in shares for this position over the two quarters is -8,118. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Wellpoint Inc. (NYSE:WLP): On 06/30/2011, Nationwide Fund Advisors reported holding 29,090 shares with a market value of $2,291,419. This comprised 0.25% of the total portfolio. On 09/30/2011, Nationwide Fund Advisors reported holding 25,697 shares with a market value of $1,677,500. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is -3,393. About Company: WellPoint Inc. is a health benefits company. The Company provides health benefits, dental and vision benefits, pharmacy benefits, life insurance, and life and disability insurance benefits. WellPoint operations include Blue Cross and Blue Shield plans.
  • Medtronic Inc. (NYSE:MDT): On 06/30/2011, Nationwide Fund Advisors reported holding 51,195 shares with a market value of $1,972,543. This comprised 0.22% of the total portfolio. On 09/30/2011, Nationwide Fund Advisors reported holding 45,634 shares with a market value of $1,516,874. This comprised 0.22% of the total portfolio. The net change in shares for this position over the two quarters is -5,561. About Company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.

(Note: Data regarding Nationwide Fund Advisors’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet